Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1475 NW 12th ave
suite 3300 (D8-4)
Miami, FL 33136Phone+1 305-243-4860Fax+1 305-243-9161- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
NYU Grossman School of MedicineResidency, Internal Medicine, 2002 - 2006
Albert Einstein College of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2009 - 2025
NY State Medical License 2004 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma Start of enrollment: 2012 Nov 19
- Carpal Tunnel/Amyloidosis Blood Sample Study Start of enrollment: 2016 Feb 24
- A Safety Study of SEA-BCMA in Patients With Multiple Myeloma Start of enrollment: 2018 Nov 01
Publications & Presentations
PubMed
- Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer Therapies.Kowalski, A., Lykon, J., Landgren, O., Diamond, B., Kaddoura, M., Maura, F., Hoffman, J., Kazandjian, D., Coffey, D. G., Coffey, D.> ;Blood Cancer Discovery. 2024 Mar 1
- 2 citationsGenomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.Francesco Maura, Eileen M Boyle, David Coffey, Kylee Maclachlan, Dylan Gagler, Benjamin Diamond, Hussein Ghamlouch, Patrick Blaney, Bachisio Ziccheddu, Anthony Cirrinc...> ;Nature Cancer. 2023 Dec 1
- Inappropriate use of technetium-99m pyrophosphate scanning for the evaluation of transthyretin amyloidosis.Crystal Lihong Yan, Nina Thakkar Rivera, James Hoffman> ;Amyloid. 2024 Mar 1
- Join now to see all
Abstracts/Posters
- Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...James E. Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceJames E. Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Hypogammaglobulinemia and Its Implications in Patients Treated with Daratumumab: A Single Institution ExperienceJames E. Hoffman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Sylvester Pursues Landmark Research Presented at International Hematology ConferenceJanuary 30th, 2023
OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesMarch 5th, 2019
Hospital Affiliations
University of Miami HospitalMiami, Florida
Jackson Health SystemMiami, Florida
UMHC-Sylvester Comprehensive Cancer CenterMiami, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
